BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24842387)

  • 1. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
    Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
    Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
    Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
    Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.
    Lee JS; Rosengart MR; Kondragunta V; Zhang Y; McMurray J; Branch RA; Choi AM; Sciurba FC
    Respir Res; 2007 Sep; 8(1):64. PubMed ID: 17868461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
    Zhang L; Cheng Z; Liu W; Wu K
    COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance of dendritic cell co-stimulation in COPD.
    Stoll P; Ulrich M; Bratke K; Garbe K; Virchow JC; Lommatzsch M
    Respir Res; 2015 Feb; 16(1):19. PubMed ID: 25775429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease.
    Chan KH; Yeung SC; Yao TJ; Ip MS; Cheung AH; Chan-Yeung MM; Mak JC;
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1193-200. PubMed ID: 20819268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema.
    Di Stefano A; Coccini T; Roda E; Signorini C; Balbi B; Brunetti G; Ceriana P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1691-1700. PubMed ID: 29872287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of C-reactive protein with disease severity in CT diagnosed emphysema.
    Omori H; Tsuji M; Sata K; Iyonaga C; Narimatsu A; Mihara S; Marubayashi T; Tomiguchi S; Nomori H; Kohrogi H; Katoh T
    Respirology; 2009 May; 14(4):551-8. PubMed ID: 19386068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.
    Bon JM; Leader JK; Weissfeld JL; Coxson HO; Zheng B; Branch RA; Kondragunta V; Lee JS; Zhang Y; Choi AM; Lokshin AE; Kaminski N; Gur D; Sciurba FC
    PLoS One; 2009 Aug; 4(8):e6865. PubMed ID: 19718453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
    de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Schmidt M; de Koning HJ; van der Aalst C; Oudkerk M; Vliegenthart R; Groen HJ; van Ginneken B; van Rikxoort EM; Zanen P
    Eur Respir J; 2015 Mar; 45(3):644-51. PubMed ID: 25614166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
    Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
    Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD.
    Gietema HA; Edwards LD; Coxson HO; Bakke PS;
    Respir Med; 2013 Aug; 107(8):1201-9. PubMed ID: 23711580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease.
    Sugiyama Y; Asai K; Yamada K; Kureya Y; Ijiri N; Watanabe T; Kanazawa H; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():765-772. PubMed ID: 28424548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1.
    Coxson HO; Leipsic J; Parraga G; Sin DD
    Am J Respir Crit Care Med; 2014 Jul; 190(2):135-44. PubMed ID: 24873985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of blood cytokines and chemokines in assessing COPD.
    Bradford E; Jacobson S; Varasteh J; Comellas AP; Woodruff P; O'Neal W; DeMeo DL; Li X; Kim V; Cho M; Castaldi PJ; Hersh C; Silverman EK; Crapo JD; Kechris K; Bowler RP
    Respir Res; 2017 Oct; 18(1):180. PubMed ID: 29065892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
    Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
    Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.
    Bhatt SP; Nath HP; Kim YI; Ramachandran R; Watts JR; Terry NLJ; Sonavane S; Deshmane SP; Woodruff PG; Oelsner EC; Bodduluri S; Han MK; Labaki WW; Michael Wells J; Martinez FJ; Barr RG; Dransfield MT;
    Respir Res; 2018 Dec; 19(1):257. PubMed ID: 30563576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
    Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
    Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.